Literature DB >> 26150607

Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.

Matthew G Sampson1, Catherine C Robertson2, Sebastian Martini3, Laura H Mariani3, Kevin V Lemley4, Christopher E Gillies2, Edgar A Otto2, Jeffrey B Kopp5, Anne Randolph3, Virginia Vega-Warner2, Felix Eichinger3, Viji Nair3, Debbie S Gipson2, Daniel C Cattran6, Duncan B Johnstone7, John F O'Toole8, Serena M Bagnasco9, Peter X Song10, Laura Barisoni11, Jonathan P Troost2, Matthias Kretzler12, John R Sedor13.   

Abstract

APOL1 variants have been associated with renal phenotypes in blacks. To refine clinical outcomes and discover mechanisms of APOL1-associated kidney injury, we analyzed clinical and genomic datasets derived from 90 black subjects in the Nephrotic Syndrome Study Network (NEPTUNE), stratified by APOL1 risk genotype. Ninety subjects with proteinuria ≥0.5 g/d were enrolled at first biopsy for primary nephrotic syndrome and followed. Clinical outcomes were determined, and renal histomorphometry and sequencing of Mendelian nephrotic syndrome genes were performed. APOL1 variants were genotyped, and glomerular and tubulointerstitial transcriptomes from protocol renal biopsy cores were analyzed for differential and correlative gene expression. Analyses were performed under the recessive model (high-risk genotype defined by two risk alleles). APOL1 high-risk genotype was significantly associated with a 17 ml/min per 1.73 m(2) lower eGFR and a 69% reduction in the probability of complete remission at any time, independent of histologic diagnosis. Neither APOL1 risk group was enriched for Mendelian mutations. On renal biopsy, high-risk genotype was associated with increased fractional interstitial area, interstitial fibrosis, and tubular atrophy. Risk genotype was not associated with intrarenal APOL1 mRNA expression levels. Differential expression analysis demonstrated an increased steady-state level of five genes associated with the high-risk genotype (CXCL9, CXCL11, and UBD in glomerulus; SNOR14B and MUC13 in tubulointerstitium). APOL1 tubulointerstitial coexpression analysis showed coexpression of APOL1 mRNA levels with a group of intrarenal transcripts that together were associated with increased interstitial fibrosis and tubular atrophy. These data indicate the high-risk APOL1 genotype confers renal risk across histopathologic diagnoses.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  APOL1; epidemiology and outcomes; genetic renal disease; glomerular disease; nephrotic syndrome; transcriptional profiling

Mesh:

Substances:

Year:  2015        PMID: 26150607      PMCID: PMC4769193          DOI: 10.1681/ASN.2014111131

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  37 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application.

Authors:  Clemens D Cohen; Karin Frach; Detlef Schlöndorff; Matthias Kretzler
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

3.  APOL1 risk variants, race, and progression of chronic kidney disease.

Authors:  Afshin Parsa; W H Linda Kao; Dawei Xie; Brad C Astor; Man Li; Chi-yuan Hsu; Harold I Feldman; Rulan S Parekh; John W Kusek; Tom H Greene; Jeffrey C Fink; Amanda H Anderson; Michael J Choi; Jackson T Wright; James P Lash; Barry I Freedman; Akinlolu Ojo; Cheryl A Winkler; Dominic S Raj; Jeffrey B Kopp; Jiang He; Nancy G Jensvold; Kaixiang Tao; Michael S Lipkowitz; Lawrence J Appel
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

4.  IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide.

Authors:  Paola Romagnani; Elena Lazzeri; Laura Lasagni; Carmelo Mavilia; Chiara Beltrame; Michela Francalanci; Mario Rotondi; Francesco Annunziato; Lucia Maurenzig; Lorenzo Cosmi; Grazia Galli; Maurizio Salvadori; Enrico Maggi; Mario Serio
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

5.  Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE).

Authors:  Laura Barisoni; Cynthia C Nast; J Charles Jennette; Jeffrey B Hodgin; Andrew M Herzenberg; Kevin V Lemley; Catherine M Conway; Jeffrey B Kopp; Matthias Kretzler; Christa Lienczewski; Carmen Avila-Casado; Serena Bagnasco; Sanjeev Sethi; John Tomaszewski; Adil H Gasim; Stephen M Hewitt
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 8.237

6.  A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha.

Authors:  S Raasi; G Schmidtke; R de Giuli; M Groettrup
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

7.  The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis.

Authors:  S Raasi; G Schmidtke; M Groettrup
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

8.  Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.

Authors:  Kaoru Ito; Alexander G Bick; Jason Flannick; David J Friedman; Giulio Genovese; Michael G Parfenov; Steven R Depalma; Namrata Gupta; Stacey B Gabriel; Herman A Taylor; Ervin R Fox; Christopher Newton-Cheh; Sekar Kathiresan; Joel N Hirschhorn; David M Altshuler; Martin R Pollak; James G Wilson; J G Seidman; Christine Seidman
Journal:  Circ Res       Date:  2013-12-30       Impact factor: 17.367

9.  Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.

Authors:  Crystal A Gadegbeku; Debbie S Gipson; Lawrence B Holzman; Akinlolu O Ojo; Peter X K Song; Laura Barisoni; Matthew G Sampson; Jeffrey B Kopp; Kevin V Lemley; Peter J Nelson; Chrysta C Lienczewski; Sharon G Adler; Gerald B Appel; Daniel C Cattran; Michael J Choi; Gabriel Contreras; Katherine M Dell; Fernando C Fervenza; Keisha L Gibson; Larry A Greenbaum; Joel D Hernandez; Stephen M Hewitt; Sangeeta R Hingorani; Michelle Hladunewich; Marie C Hogan; Susan L Hogan; Frederick J Kaskel; John C Lieske; Kevin E C Meyers; Patrick H Nachman; Cynthia C Nast; Alicia M Neu; Heather N Reich; John R Sedor; Christine B Sethna; Howard Trachtman; Katherine R Tuttle; Olga Zhdanova; Gastòn E Zilleruelo; Matthias Kretzler
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

10.  Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.

Authors:  Brendan Nichols; Prachi Jog; Jessica H Lee; Daniel Blackler; Michael Wilmot; Vivette D'Agati; Glen Markowitz; Jeffrey B Kopp; Seth L Alper; Martin R Pollak; David J Friedman
Journal:  Kidney Int       Date:  2014-08-06       Impact factor: 10.612

View more
  61 in total

1.  JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy.

Authors:  Jianling Tao; Laura Mariani; Sean Eddy; Holden Maecker; Neeraja Kambham; Kshama Mehta; John Hartman; Weiqi Wang; Matthias Kretzler; Richard A Lafayette
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-30       Impact factor: 8.237

Review 2.  Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.

Authors:  Kirk N Campbell; James A Tumlin
Journal:  Am J Nephrol       Date:  2018-05-31       Impact factor: 3.754

Review 3.  One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.

Authors:  Jeffrey B Kopp; Avi Z Rosenberg
Journal:  Adv Anat Pathol       Date:  2019-05       Impact factor: 3.875

Review 4.  Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology.

Authors:  Laura H Mariani; William F Pendergraft; Matthias Kretzler
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-14       Impact factor: 8.237

Review 5.  APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.

Authors:  Pazit Beckerman; Katalin Susztak
Journal:  Trends Mol Med       Date:  2018-06-07       Impact factor: 11.951

6.  Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Authors:  Pazit Beckerman; Jing Bi-Karchin; Ae Seo Deok Park; Chengxiang Qiu; Patrick D Dummer; Irfana Soomro; Carine M Boustany-Kari; Steven S Pullen; Jeffrey H Miner; Chien-An A Hu; Tibor Rohacs; Kazunori Inoue; Shuta Ishibe; Moin A Saleem; Matthew B Palmer; Ana Maria Cuervo; Jeffrey B Kopp; Katalin Susztak
Journal:  Nat Med       Date:  2017-02-20       Impact factor: 53.440

Review 7.  Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry.

Authors:  Kimberly J Reidy; Rebecca Hjorten; Rulan S Parekh
Journal:  Curr Opin Pediatr       Date:  2018-04       Impact factor: 2.856

Review 8.  Drug discovery in focal and segmental glomerulosclerosis.

Authors:  Nick Pullen; Alessia Fornoni
Journal:  Kidney Int       Date:  2016-04-23       Impact factor: 10.612

9.  Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome.

Authors:  Hanna Debiec; Claire Dossier; Eric Letouzé; Christopher E Gillies; Marina Vivarelli; Rosemary K Putler; Elisabet Ars; Evelyne Jacqz-Aigrain; Valery Elie; Manuela Colucci; Stéphanie Debette; Philippe Amouyel; Siham C Elalaoui; Abdelaziz Sefiani; Valérie Dubois; Tabassome Simon; Matthias Kretzler; Jose Ballarin; Francesco Emma; Matthew G Sampson; Georges Deschênes; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2018-06-14       Impact factor: 10.121

10.  Complete Remission in the Nephrotic Syndrome Study Network.

Authors:  Debbie S Gipson; Jonathan P Troost; Richard A Lafayette; Michelle A Hladunewich; Howard Trachtman; Crystal A Gadegbeku; John R Sedor; Lawrence B Holzman; Marva M Moxey-Mims; Kalyani Perumal; Frederick J Kaskel; Peter J Nelson; Katherine R Tuttle; Serena M Bagnasco; Marie C Hogan; Katherine M Dell; Gerald B Appel; John C Lieske; Titilayo O Ilori; Christine B Sethna; Fernando C Fervenza; Susan L Hogan; Patrick H Nachman; Avi Z Rosenberg; Larry A Greenbaum; Kevin E C Meyers; Stephen M Hewitt; Michael J Choi; Jeffrey B Kopp; Olga Zhdanova; Jeffrey B Hodgin; Duncan B Johnstone; Sharon G Adler; Carmen Avila-Casado; Alicia M Neu; Sangeeta R Hingorani; Kevin V Lemley; Cynthia C Nast; Tammy M Brady; Laura Barisoni-Thomas; Alessia Fornoni; J Charles Jennette; Daniel C Cattran; Matthew B Palmer; Keisha L Gibson; Heather N Reich; Michele H Mokrzycki; Kamalanathan K Sambandam; Gaston E Zilleruelo; Christoph Licht; Matthew G Sampson; Peter Song; Laura H Mariani; Matthias Kretzler
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-10       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.